Prophylactic Ureaplasma-directed Antimicrobials in Lung Donors Can Prevent Fatal Hyperammonemia
- PMID: 33617207
- PMCID: PMC7905692
- DOI: 10.1097/TP.0000000000003540
Prophylactic Ureaplasma-directed Antimicrobials in Lung Donors Can Prevent Fatal Hyperammonemia
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Anwar S, Gupta D, Ashraf MA, et al. Symptomatic hyperammonemia after lung transplantation: Lessons learnt. Hemodial Int 2014;18:185–191. - PubMed
-
- Rueda JF, Caldwell C, Brennan DC. Successful treatment of hyperammonemia after lung transplantation. Ann Intern Med 1998;128:956–957. - PubMed
-
- Krutsinger D, Pezzulo A, Blevins AE, et al. Idiopathic hyperammonemia after solid organ transplantation: Primarily a lung problem? A single-center experience and systematic review. Clin Transplant 2017;31. - PubMed
-
- Bharat A, Scott Budinger GR, Ison MG. Donor-derived ureaplasma is a potentially lethal infection in lung allograft recipients. J Heart Lung Transplant 2017;36:917–918. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical